🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to: * Find out if the study drugs Afatinib an...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-12-31
Trial ID
NCT01999985
Treatments Being Tested
This trial is divided into Part A and Part B. The primary objective of Part...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2012-07
Trial ID
NCT01647711
Treatments Being Tested
Proof of principle phase 1b / randomised phase 2 study of afatinib penetrat...
Status
Terminated
Location
Cambridge University Hospitals NHS Foundation Trust
Start Date
2015-03-10
Trial ID
NCT02768337
Treatments Being Tested
This study will evaluate the safety, tolerability, drug levels, molecular e...
Status
Active Not Recruiting
Location
Local Institution - 001-826
Start Date
2019-01-15
Trial ID
NCT03785249
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
The aim of the COMBINATION trial is to prospectively study the sequential a...
Status
Completed
Location
Amsterdam UMC, location VUmc
Start Date
2022-01-04
Trial ID
NCT05298176
Treatments Being Tested
This is a Phase 1b, open-label, multi-center, dose-escalation and dose expa...
Status
Active Not Recruiting
Location
ArriVent Investigative Site
Start Date
2022-06-30
Trial ID
NCT05364073
Treatments Being Tested
This study is researching whether the combination of Afatinib and Pemigatin...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2024-04-17
Trial ID
NCT06302621
Treatments Being Tested
The goal of this clinical trial is to learn if Afatinib plus Palbociclib wo...
Status
Recruiting
Location
West China Hospital
Start Date
2025-09-10
Trial ID
NCT06753747
Treatments Being Tested